Quadrature Capital’s ACELYRIN SLRN Stock Holding History

Quadrature Capital’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,246	Closed	-$25.3K	–	1452
2025 Q1	$25.3K	Buy	+10,246	New	+$24.4K	﹤0.01%	1022

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quadrature Capital's SLRN Position: Q2 2025 in Review

Quadrature Capital sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 10,246 shares — an estimated $25.3K sold.

Quadrature Capital first reported a position in SLRN in Q1 2025 and held it in 1 quarter. The position peaked at $25.3K in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Quadrature Capital reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Quadrature Capital sold 10,246 ACELYRIN shares in Q2 2025, an estimated $25.3K.
Quadrature Capital first reported a position in ACELYRIN in Q1 2025 and held it in 1 quarter.
Quadrature Capital's ACELYRIN position peaked at $25.3K in Q1 2025.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Quadrature Capital's 13F filing for Q2 2025, filed 13 Aug 2025.